Clinical Trials Directory

Trials / Sponsors / Sparrow Pharmaceuticals

Sparrow Pharmaceuticals

Industry · 8 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingClofutriben Pharmacokinetics in Patients With Impaired Renal Function
Moderate Renal Impairment
Phase 12025-11-30
RecruitingTrial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 22025-11-29
CompletedPharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone
Healthy Participants
Phase 12025-10-03
CompletedSPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
Autonomous Cortisol Secretion (ACS), ACTH-Independent Cushing Syndrome, ACTH-Independent Adrenal Cushing Syndrome, Somatic
Phase 22023-07-01
CompletedSPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Cushing's Syndrome I, Cushing Disease Due to Increased ACTH Secretion, Cortisol Excess
Phase 22022-09-01
CompletedA Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)
Polymyalgia Rheumatica
Phase 22022-07-22
TerminatedA Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
Polymyalgia Rheumatica
Phase 12022-02-22
CompletedA Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
Type 2 Diabetes Mellitus in Obese, Obesity, Type2Diabetes
Phase 12021-07-23